Non-Alcoholic Fatty Liver Disease / Metabolic Dysfunction-Associated Steatotic Liver Disease

Non-Alcoholic Fatty Liver Disease / Metabolic Dysfunction-Associated Steatotic Liver Disease is indexed under Gastrointestinal, Hepatic. Also known as NAFLD, MASLD, NASH, fatty liver.

US prevalence

~24% of U.S. adults have NAFLD; ~1.5-6.5% have NASH Source: NIDDK — Definition & Facts of NAFLD & NASH. Federal source. Label: VERIFIED.

ICD-10-CM codes

K76.0, K75.81

Typical onset

Any age; highest in 40-60; increasing in children

Course

progressive

Body systems

hepatic, cardiovascular

Sex differences

Slightly higher in men; NASH may be more progressive in women post-menopause

Racial and ethnic differences

Highest in Hispanic Americans; higher in white than Black Americans

What this page does not establish

These figures describe populations, not individuals, and none of them is a diagnosis or a treatment recommendation. Prevalence estimates are approximate and reflect published ranges. Disparity figures are reported patterns, not causes.

Taxonomy last reviewed 2026-05-19. Each figure on the interactive page carries its own source and retrieval date, which can be later than this review.

Browse all indexed conditions · Source registry · Methodology · Known limitations